| 产品描述: | (Rac)-Etavopivat ((Rac)-FT-4202) is an isomer of Etavopivat . Etavopivat is an orally active erythrocyte pyruvate kinase-R (PKR) activator that can be used in studies of sickle cell disease and other haemoglobinopathies. |
| 体外研究: |
Etavopivat (20 μM, 4 h)可以改善人红细胞中血红蛋白-氧亲和力并降低了镰状点 (PoS)。 |
| 体内研究: |
Etavopivat(口服,3-22mg/kg,每天一次,5天)在 8 mg/kg和 22 mg/kg 的剂量下引起食蟹猴 2,3-DPG 和 ATP 的增加。 |
| 参考文献: |
1. Patricia Schroeder, et al. Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease. J Pharmacol Exp Ther. 2022 Mar;380(3):210-219.
|
| 保存条件: |
-20°C |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.186 ml |
10.929 ml |
21.858 ml |
| 5 mM |
0.437 ml |
2.186 ml |
4.372 ml |
| 10 mM |
0.219 ml |
1.093 ml |
2.186 ml |
| 50 mM |
0.044 ml |
0.219 ml |
0.437 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |